Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Nextage Therapeutics Ltd
  6. Summary
    NXTG   IL0004330119

NEXTAGE THERAPEUTICS LTD

(NXTG)
 SummaryChartsNewsCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Tel Aviv Stock Exchange
11/24/2021 11/25/2021 11/28/2021 11/29/2021 11/30/2021 Date
3.09 3.07 3.034 3.054 3.05 Last
7948 5000 545 2954 105 Volume
+0.62% -0.65% -1.17% +0.66% -0.13% Change
Estimated financial data (e)
Sales 2018 0,38 M 0,12 M 0,12 M
Net income 2018 -8,74 M -2,78 M -2,78 M
Net Debt 2018 0,48 M 0,15 M 0,15 M
P/E ratio 2018 -1,17x
Yield 2018 -
Sales 2019 0,30 M 0,09 M 0,09 M
Net income 2019 -2,09 M -0,66 M -0,66 M
Net cash position 2019 1,20 M 0,38 M 0,38 M
P/E ratio 2019 -7,50x
Yield 2019 -
Capitalization 79,7 M 25,2 M 25,4 M
EV / Sales 2018 29,9x
EV / Sales 2019 61,9x
Nbr of Employees -
Free-Float 9,32%
More Financials
Company
Nextage Therapeutics Ltd, formerly known asMicromedic Technologies Ltd,is an Israel-based company engaged in the development and commercialization of cancer diagnostic products. Its portfolio includes a range of cancer and cancer-related indications including colorectal cancer, breast cancer, cervical cancer, bladder cancer, lung cancer, and diagnostic tools for personalized treatment. Micromedic forms a cluster... 
More about the company
All news about NEXTAGE THERAPEUTICS LTD
05/24NEXTAGE THERAPEUTICS : MindMed Announces Launch of Collaboration with Nextage Therapeutics..
PR
2020Micromedic Technologies Ltd announced that it has received ILS 8.163992 million in fund..
CI
2020Micromedic Technologies Ltd Auditor Raises 'Going Concern' Doubt
CI
2019Micromedic Technologies Ltd announced that it expects to receive ILS 0.5 million in fun..
CI
2019Nextage Cannabis Innovation Ltd. signed an agreement to acquire Micromedic Technologies..
CI
2019Micromedic Technologies Ltd Auditor Raises 'Going Concern' Doubt
CI
2018Micromedic Technologies Ltd Auditor Raises 'Going Concern' Doubt
CI
2018Micromedic Technologies Reports Successful Clinical Study Results for the Detection of ..
CI
More news
News in other languages on NEXTAGE THERAPEUTICS LTD

- No features available -

More news
Chart NEXTAGE THERAPEUTICS LTD
Duration : Period :
Nextage Therapeutics Ltd Technical Analysis Chart | NXTG | IL0004330119 | MarketScreener
Income Statement Evolution
Managers and Directors
Maiki Yoeli Chief Executive Officer
Itai Bar-Natan Chief Financial Officer
Israel Makov Chairman
Keren Gueta-Milshtein Director-Research & Development
Doron Debbie Independent Director
Sector and Competitors